| scholarly article | Q13442814 |
| P50 | author | María Galán | Q57352557 |
| Mercedes Camacho | Q41875511 | ||
| José Martínez-González | Q47504227 | ||
| P2093 | author name string | Cristina Rodriguez | |
| José Antonio Rodríguez | |||
| Mar Orriols | |||
| Saray Varona | |||
| Silvia Aguiló | |||
| Jaume Dilmé | |||
| P2860 | cites work | NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells | Q61864764 |
| Lysyl oxidase (LOX) in vascular remodelling | Q61864787 | ||
| Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm | Q71938798 | ||
| Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice | Q73652351 | ||
| Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms | Q77380951 | ||
| A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice | Q81488583 | ||
| Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature | Q84147910 | ||
| Improved synthesis and structural reassignment of MC1568: a class IIa selective HDAC inhibitor | Q87142814 | ||
| Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes | Q39842424 | ||
| Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. | Q41697756 | ||
| Understanding abdominal aortic aneurysm | Q42048833 | ||
| Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. | Q44342238 | ||
| Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. | Q45075496 | ||
| Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth | Q45873353 | ||
| Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration | Q45877601 | ||
| Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001. | Q46052019 | ||
| Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma | Q46167944 | ||
| Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding | Q46870302 | ||
| Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms | Q24623052 | ||
| Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity | Q28508698 | ||
| Cooperation between complexes that regulate chromatin structure and transcription | Q29614769 | ||
| Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | Q29615649 | ||
| Anticancer activities of histone deacetylase inhibitors | Q29616624 | ||
| Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy | Q33929939 | ||
| The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines | Q34015778 | ||
| Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. | Q34206478 | ||
| Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice | Q34433103 | ||
| Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms. | Q34485800 | ||
| Abdominal aortic aneurysm: pathogenesis and implications for management | Q34566262 | ||
| Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group | Q34622291 | ||
| Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition | Q34780528 | ||
| Targeting inflammation in heart failure with histone deacetylase inhibitors | Q35016989 | ||
| Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm | Q35167994 | ||
| Detection, management, and prospects for the medical treatment of small abdominal aortic aneurysms | Q35578689 | ||
| Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model | Q36129293 | ||
| Inflammation and cellular immune responses in abdominal aortic aneurysms | Q36404719 | ||
| Histone deacetylases--an important class of cellular regulators with a variety of functions | Q36766483 | ||
| Detrimental effect of class-selective histone deacetylase inhibitors during tissue regeneration following hindlimb ischemia | Q37095364 | ||
| ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice | Q37200287 | ||
| Microvascular COX-2/mPGES-1/EP-4 axis in human abdominal aortic aneurysm. | Q37305427 | ||
| Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease. | Q37369595 | ||
| Histone deacetylase inhibitors: keeping momentum for neuromuscular and cardiovascular diseases treatment | Q37708759 | ||
| Pathophysiology and epidemiology of abdominal aortic aneurysms | Q37809741 | ||
| Can pharmacologic agents slow abdominal aortic aneurysm growth? | Q38010892 | ||
| Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms. | Q38025669 | ||
| Immunomodulatory effects of histone deacetylase inhibitors | Q38051693 | ||
| Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. | Q39168362 | ||
| Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms | Q39738340 | ||
| The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells. | Q39824443 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | abdominal aortic aneurysm | Q2256736 |
| P304 | page(s) | 541-552 | |
| P577 | publication date | 2016-03-17 | |
| P1433 | published in | Disease Models & Mechanisms | Q1524006 |
| P1476 | title | Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors | |
| P478 | volume | 9 |
| Q55455553 | Aging-Induced Biological Changes and Cardiovascular Diseases. |
| Q90170910 | Angiotensin II represses Npr1 expression and receptor function by recruitment of transcription factors CREB and HSF-4a and activation of HDACs |
| Q53119799 | Down-regulation of Fibulin-5 is associated with aortic dilation: role of inflammation and epigenetics. |
| Q51762349 | Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities. |
| Q52627695 | Epigenetic regulation of vascular NADPH oxidase expression and reactive oxygen species production by histone deacetylase-dependent mechanisms in experimental diabetes. |
| Q92848013 | Epigenetics and vascular diseases |
| Q39100045 | Genetic and Epigenetic Regulation of Aortic Aneurysms |
| Q90355401 | Histone Acetyltransferase-Dependent Pathways Mediate Upregulation of NADPH Oxidase 5 in Human Macrophages under Inflammatory Conditions: A Potential Mechanism of Reactive Oxygen Species Overproduction in Atherosclerosis |
| Q98291727 | Histone Deacetylase Inhibition Attenuates Aortic Remodeling in Rats under Pressure Overload |
| Q37274168 | NOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress |
| Q50204446 | The epigenetic promise to improve prognosis of heart failure and heart transplantation |
Search more.